Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial.

Autor: Leypoldt, Lisa B.¹ (AUTHOR) l.leypoldt@uke.de, Gavriatopoulou, Maria² (AUTHOR), Besemer, Britta³ (AUTHOR), Salwender, Hans⁴ (AUTHOR), Raab, Marc S.⁵ (AUTHOR), Nogai, Axel⁶ (AUTHOR), Khandanpour, Cyrus^7,8 (AUTHOR), Runde, Volker⁹ (AUTHOR), Jauch, Anna¹⁰ (AUTHOR), Zago, Manola¹¹ (AUTHOR), Martus, Peter¹² (AUTHOR), Goldschmidt, Hartmut¹³ (AUTHOR), Bokemeyer, Carsten¹ (AUTHOR), Dimopoulos, Meletios A.² (AUTHOR), Weisel, Katja C.¹ (AUTHOR) k.weisel@uke.de

Publikováno v: Cancers. Sep2023, Vol. 15 Issue 18, p4667. 13p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial

Autor: Weisel, Katja, Besemer, Britta ^*, Haenel, Mathias ^*, Lutz, Raphael ^*, Mann, Christoph ^*, Munder, Markus ^*, Goerner, Martin ^*, Reinhardt, Hans Christian, Nogai, Axel ^*, Ko, Yon-Dschun ^*, De Wit, Maike ^*, Salwender, Hans ^*, Scheid, Christoph ^*, Graeven, Ullrich ^*, Peceny, Rudolf, Staib, Peter ^*, Dieing, Annette ^*, Jauch, Anna ^*, Zago, Manola ^*, Benner, Axel ^*, Tichy, Diana ^*, Bokemeyer, Carsten ^*, Goldschmidt, Hartmut, Leypoldt, Lisa B. ^*

Publikováno v: In Blood 15 November 2022 140 Supplement 1:1836-1838

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience.

Autor: Ghandili, Susanne, Alihodzic, Dzenefa, Wiessner, Christian, Bokemeyer, Carsten, Weisel, Katja, Leypoldt, Lisa B.

Publikováno v: Annals of Hematology; Jan2023, Vol. 102 Issue 1, p117-124, 8p